Please enable Javascript
Wafik El-Deiry, MD, PhD, FACP
Articles by Wafik El-Deiry, MD, PhD, FACP
Utilizing TAS-102 and Regorafenib for Future Studies
Wafik El-Deiry, MD, PhD, FACP
Colorectal Cancer
|
March 13, 2025
Dr. El-Deiry expands on reducing ALDH1 expression in HT29 cells, and the benefits of targeting ERK1/2 and STAT3 activation.
View More
Regorafenib and TAS-102 for GI Cancers
Wafik El-Deiry, MD, PhD, FACP
Colorectal Cancer
|
March 13, 2025
Dr. Wafik El-Deiry of Brown University discusses his study on regorafenib with TAS-102 for colorectal cancer.
View More